These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetes. Kahn SE; Zinman B Diabetes Care; 2007 Jun; 30(6):1672-6. PubMed ID: 17351271 [No Abstract] [Full Text] [Related]
7. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes. Charbonnel B Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387 [No Abstract] [Full Text] [Related]
8. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study. Brauchli YB; Jick SS; Curtin F; Meier CR J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825 [TBL] [Abstract][Full Text] [Related]
9. Goodbye avandia! Alzaid AA Saudi Med J; 2010 Dec; 31(12):1301-2. PubMed ID: 21135990 [No Abstract] [Full Text] [Related]
10. The value equation for rosiglitazone and pioglitazone in older persons. Zarowitz BJ Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172 [No Abstract] [Full Text] [Related]
11. [Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions]. Matthaei S MMW Fortschr Med; 2007 Apr; 149(15):53. PubMed ID: 17668779 [No Abstract] [Full Text] [Related]
12. Triple oral therapy for type 2 diabetes. Bell DS Diabetes Res Clin Pract; 2007 Dec; 78(3):313-5. PubMed ID: 17320237 [No Abstract] [Full Text] [Related]
13. The truth about rosiglitazone (avandia). Ledbetter C; Laustsen G Nurse Pract; 2008 Jun; 33(6):10-1. PubMed ID: 18528195 [No Abstract] [Full Text] [Related]
14. Rosiglitazone + glimepiride: new drug. Another combination product to avoid. Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795 [No Abstract] [Full Text] [Related]
17. Pioglitazone/glimepiride (Duetact) for diabetes. Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966 [No Abstract] [Full Text] [Related]
18. The rosiglitazone controversy: the Indian perspective. Mohan V; Joshi SR J Assoc Physicians India; 2007 Jul; 55():477-80. PubMed ID: 17907495 [No Abstract] [Full Text] [Related]
19. Suppression of post-prandial hyperglycaemia by pioglitazone improved islet fibrosis and macrophage migration in the Goto-Kakizaki rat. Mizukami H; Wada R; Yonezawa A; Sugawara A; Yagihashi S Diabetes Obes Metab; 2008 Sep; 10(9):791-4. PubMed ID: 18937646 [No Abstract] [Full Text] [Related]
20. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]